换一批
换一批Pembrolizumab versus paclitaxel for previously treated, advanced gastric or gastro-oesophageal junction cancer (KEYNOTE-061): a randomised, open-label, controlled, phase 3 trial
作者：
Shitara, Kohei [1]
;
Ozguroglu, Mustafa [2]
;
Bang, Yung-Jue [3]
;
Di Bartolomeo, Maria [4]
;
Mandala, Mario [5]
;
Ryu, Min-Hee [6]
;
Fornaro, Lorenzo [7]
;
Olesinski, Tomasz [8]
;
Caglevic, Christian [9]
;
Chung, Hyun C. [10]
;
Muro, Kei [11]
;
Goekkurt, Eray [12]
;
Mansoor, Wasat [13]
;
McDermott, Raymond S. [14]
;
Shacham-Shmueli, Einat [15]
;
Chen, Xinqun [16]
;
Mayo, Carlos [17]
;
Kang, S. Peter ;
Ohtsu, Atsushi ;
Fuchs, Charles S.
作者单位：
Adelaide & Meath Hosp, Dublin, Ireland
[1]
Smilow Canc Hosp, Yale Canc Ctr, New Haven, CT USA
[2]
Maria Sklodowska Curie Mem Canc Ctr, Warsaw, Poland
[3]
Christie Hosp NHS Fdn Trust, Manchester, Lancs, England
[4]
Merck & Co Inc, Kenilworth, NJ USA
[5]
Fdn IRCCS Ist Nazl Tumori, Milan, Italy
[6]
Azienda Osped Univ Pisana, Pisa, Italy
[7]
Sheba Med Ctr, Ramat Gan, Israel
[8]
Aichi Canc Ctr Hosp, Nagoya, Aichi, Japan
[9]
Papa Giovanni XXIII Hosp, Bergamo, Italy
[10]
HOPE, Hamburg, Germany
[11]
Fdn Arturo Lopez Perez Clin Alemana Santiago, Santiago, Chile
[12]
Seoul Natl Univ, Coll Med, Seoul, South Korea
[13]
Yonsei Univ, Coll Med, Yonsei Canc Ctr, Seoul, South Korea
[14]
Istanbul Univ, Cerrahpasa Sch Med, Istanbul, Turkey
[15]
Natl Canc Ctr Hosp East, Kashiwa, Chiba 2770882, Japan
[16]
Univ Ulsan, Coll Med, Asan Med Ctr, Seoul, South Korea
[17]
期刊：
《The Lancet》
2018年392卷10142期123-133页
发布时间：
2019-04-17
- 翻译满意度评价：
- 提交
- 浏览：5
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
